Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 920 results for "gsk"

Early results from GSK and NIH's Phase I Ebola vaccine show promise
Pharma Letter

Major Ebola Breakthrough As GlaxoSmithKline (GSK) Reports Prom...

GSK cruised ahead of its competitors Wednesday as it announced positive Phase I trial results for its Ebola vaccine candidate, giving the world a glimmer of hope against the deadly virus Page 1 of 2 Click Ticker to See live coverage ... Bidness Etc, 2 hours ago

284 images for gsk

Centre For Infectious Disease Research and Policy, 1 day ago
Centre For Infectious Disease Research and Policy, 1 day ago
Digital Look, 1 day ago
Pharma Letter, 23 hours ago
Invezz, 1 day ago
Reuters, 4 hours ago
The Hindu, 1 day ago
CTV News, 1 day ago
Japan Times, 1 day ago
Eye Witness News, 1 hour ago

Glaxo backs out of development deal with Dynavax

07:41 ET | By: Douglas W. House, SA News Editor GlaxoSmithKline (NYSE:GSK) declines to exercise its option to license Dynavax's (NASDAQ:DVAX) DV1179, an investigational bifunctional inhibitor of toll-like receptors (TLR) 7 and 9, after it failed ...
 Seeking Alpha49 minutes ago FTC gives thumbs up to Glaxo/Novartis transaction  Seeking Alpha1 day ago FTC puts conditions on GSK/Novartis consumer JV  Pharma Letter22 hours ago GSK-Novartis deal gets FTC approval  MoneyAM1 day ago
[x]  

Dynavax Regains Full Rights to Investigational TLR 7/9 Inhibitor DV1179 Following Expiration of Collaboration With GSK

From the Wires Nov. 28, 2014 06:00 AM BERKELEY, CA -- (Marketwired) -- 11/28/14 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it has regained full rights to DV1179, an investigational bifunctional inhibitor of ...
 Sys-Con India2 hours ago Dynavax Technologies : Regains Full Rights to Investigational TLR 7/9 Inhibitor DV1179 Following Expiration of Collaboration With GSK  4 Traders2 hours ago Dynavax Regains Full Rights To DV1179, Investigational TLR 7/9 Inhibitor  RTTNews.com2 hours ago
[x]  
Invezz

Thursday newspaper round-up: Scotland, GSK, BG, Stagecoach

Scottish MPs will be entitled to vote on UK budgets even though control over income tax will soon be transferred over to the Edinburgh parliament, Labour has revealed shortly before the publication
 Yahoo! UK and Ireland1 day ago GSK Novartis deal clears reg hurdles  Pharma In Focus10 hours ago GlaxoSmithKline (GSK) Asks Shareholders To Vote On Novartis AG Deal  Bidness Etc3 days ago Novartis deal up to GSK shareholders  Pharma In Focus2 days ago
[x]  
Health Canal

GSK's Ebola Vaccine First Phase Trial Shows Success

07:38 PM EST A 39-year-old woman, the first participant enrolled in VRC 207, receives a dose of the investigational NIAID/GSK Ebola vaccine at the NIH Clinical Center in Bethesda, Md. on September 2 (Photo : NIAID) An experimental vaccine ...
 Counsel & Heal12 hours ago GSK, U.S. Government Experimental Ebola Vaccine Shown To Be Safe In Human Trials: NIH  Austin American Statesman1 day ago GSK Ebola vaccine trials show encouraging results  KiniBiz1 day ago NIAID/GSK experimental Ebola vaccine appears safe, prompts immune response  EurekAlert!1 day ago
[x]  
IOL

GSK fires executive who raised complaint

London - Britain's biggest drugmaker, GlaxoSmithKline, fired an executive from its South African unit for refusing to appear for a performance review, which was called a week after he complained of racial discrimination in the workplace, Bloomberg ...
 IOL9 hours ago Glaxo Fires Executive Who Raised South Africa Race Complaint  Bloomberg16 hours ago GSK fires SA exec who raised race complaint  Eye Witness News1 hour ago GSK fires executive who raised race complaint in South Africa  Reuters4 hours ago
[x]  

GSK publishes first phase 1 trail results of a candidate ebola vaccine

First results from a small phase 1 trial published recently in the New England Journal of Medicine show that a GSK/NIH Ebola candidate vaccine was well-tolerated and produced an immunological response in each of the 20 healthy adult volunteers in ...
 PharmaBiz7 hours ago Ebola trial showed promising results  Mbendi21 hours ago GSK statement on first phase 1 trial results of a candidate Ebola vaccine  Noodls1 day ago
American Banking News

GlaxoSmithKline plc Research Coverage Started at BNP Paribas (GSK)

Equities research analysts at BNP Paribas started coverage on shares of GlaxoSmithKline plc (NYSE:GSK) in a research note issued to investors on Tuesday, TheFlyOnTheWall.com reports. The firm set an underperform rating on the stock. GlaxoSmithKline ...
 Mideast Time9 hours ago GlaxoSmithKline plc Coverage Initiated at BNP Paribas (GSK)  WKRB News20 hours ago GlaxoSmithKline plc Receives Sell Rating from Liberum Capital (GSK)  Mideast Time2 days ago GlaxoSmithKline plc Receives New Coverage from Analysts at BNP Paribas (GSK)  American Banking News2 days ago
[x]  
Bio Spectrum Asia

GSK makes multi-million dollar investment in Australian plant

lia will invest AU$$31m in the latest manufacturing technology to expand its Boronia site in the outer eastern suburbs of Melbourne. The expansion will include the introduction of high speed blow-fill-seal (BFS) machinery specifically developed ...
 Manufacturing Chemist1 hour ago GSK Australia Invests in Aseptic Filling  PharmTech.com6 days ago GSK eyes emerging markets with $27 mn investment  Bio Spectrum Asia1 week ago GSK expands Australian high-tech manufacturing facility  Noodls1 week ago
American Banking News

Recent Analysts Ratings Updates for GlaxoSmithKline plc (GSK)

GlaxoSmithKline plc (NYSE: GSK) received a number of price target changes and ratings updates during the last week: GlaxoSmithKline plc (NYSE:GSK) opened at 46.28 on Wednesday. GlaxoSmithKline plc has a 52 week low of $41.91 and a 52 week high of ...
 American Banking News15 hours ago Is It Time To Buy GlaxoSmithKline plc?  Yahoo! UK and Ireland3 days ago GlaxoSmithKline plc (GSK) Investment Analysts Weekly Ratings Changes  Ticker Report4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less